A statistical analysis of factors predisposing patients to heparin resistance

Perfusion

Volumn 21, Issue 2, 2006, Pages 99-103

  Chan, Tanee ^a   Hwang, Nian Chih ^b   Lim, Chong Hee ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG RESISTANCE; ELECTIVE SURGERY; FEMALE; HEART SURGERY; HEMATOLOGY; HEMODYNAMICS; HEPARINIZATION; HUMAN; HUMAN CELL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS;

CARDIOPULMONARY BYPASS; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33645785049     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659106pf855oa     Document Type: Article

References (20)

1. Staples MH, Dunton RF, Karlson KJ, Leonardi HK, Berger RL. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. Ann Thorac Surg 1994; 57: 1211-16.
2. Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC. Heparin resistance during cardiopulmonary bypass: the role of heparin pretreatment. J Thorac Cardiovasc Surg 1983; 85: 346-53.
3. Dietrich W, Spannagl M, Schramm W, Vogt W, Barankay A, Richter JA. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102: 505-14.
4. Cloyd GM, D'Ambra MN, Akins CW. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1987; 94: 535-38.
5. Denson KE. Ratio of Factor VIII-related antigen and Factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res 1997; 10: 107-19.
6. Ansell J, Deykin D. Heparin induced thrombocytopenia and recurrent thromboembolism. Am J Hematol 1980; 8: 325-32.
7. Mabry CD, Read RC, Thompson BW, Williams GD, White HJ. Identification of heparin resistance during cardiac and vascular surgery. Arch Surg 1979; 114: 128-35.
8. Ranucci M, Isgro G, Cazzamoga A et al. Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion 1999; 14: 437-42.
9. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: 829-36.
10. White PW, Sadd JR, Nonsel RE. Thrombotic complications of heparin therapy. Ann Surg 1979; 190: 595-608.
11. Carreras LO. Thrombosis and thrombocytopenia induced by heparin. Scand J Haematol 1980; 25 (Suppl 36): 64-80.
12. Kapsch D, Silver D. Heparin induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 1981; 116: 1423-27.
13. Michalski R, Lane DA, Pepper DS, Kakkar VV. Neutralization of heparin in plasma by platelet factor 4 and protamine. Br J Haematol 1978; 38: 561-71.
14. Horne MK, Chao SC. Heparin binding to resting and activated platelets. Blood 1989; 74: 238-43.
15. Marciniak E, Gockermann JP. Heparin-induced decrease in circulating antithrombin-III. Lancet 1977; 2: 587-84.
16. Conard J, LeCompte T, Horellou MH, Cazenave B, Sanama M. AT-III in patients treated with subcutaneous or intravenous heparin. Thromb Res 1981; 22: 507-11.
17. O'Brien JR, Etherington MD. Effect of heparin and warfarin on AT-III. Lancet 1977; 2: 1232.
18. Nicholson SC, Keeling DM, Sinclair ME et al. Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass. Br J Anaesth 2001; 87: 844-47.
19. Linden MD, Schneider M, Baker S, Erber WN. Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2004; 18: 131-35.
20. Pulimood TB, Park GR. Debate: albumin administration should be avoided in the critically ill. Crit Care 2000; 4(3): 151-55.